NeuroFormer:使用EEG信号检测阿尔茨海默病的深度学习框架
IEEE journal of biomedical and health informatics
|August 22, 2025
概括
一个新的深度学习模型NeuroFormer使用EEG信号准确地分类阿尔茨海默病 (AD) 和前性痴呆症 (FTD). 这项技术为早期痴呆症诊断提供了一个有前途的工具.
科学领域:
- 神经科学
- 人工智能
- 医疗诊断
背景情况:
- 阿尔茨海默病 (AD) 和前性痴呆症 (FTD) 是神经退行性疾病,症状重叠,使诊断复杂化.
- 准确及时诊断对于有效的痴呆症治疗和干预计划至关重要.
- 目前的诊断方法因症状异质性和复杂的病理机制而面临挑战.
研究的目的:
- 开发一种新的深度学习架构,NeuroFormer,用于对EEG信号进行分类.
- 通过非侵入性神经生理测量,区分阿尔茨海默病 (AD),前性痴呆 (FTD) 和健康对照.
- 为早期发现痴呆症建立一个强大的诊断框架.
主要方法:
- 提出NeuroFormer,一个集光谱处理,神经动态,囊路由和注意力机制的深度学习模型.
- 使用通过非侵入性神经生理仪器捕获的EEG信号.
- 使用动态光谱门,图形卷曲和多尺度适应性特征金字塔来进行时空特征提取.
主要成果:
- 对于AD,FTD和CN,NeuroFormer的分类准确率达到了95. 76%.
- 在所有关键评估指标上,该模型的表现明显优于基准模型.
- 从原始EEG数据中有效提取有区别的时空特征.
结论:
- 作为一种以测量为导向的痴呆症诊断框架, NeuroFormer具有显著的潜力.
- 该模型可以使用EEG仪器早期准确地分类与痴呆相关的疾病.
- 这种方法提供了一种非侵入性方法来区分AD,FTD和健康个体.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


